MedTrace Logo

National Congenital Heart Disease Audit

NCT02303535 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 120000

Last updated 2016-11-04

No results posted yet for this study

Summary

The National Institute of Cardiovascular Outcomes Research (NICOR) collects data and produces analysis to enable hospitals and healthcare improvement bodies to monitor and improve the quality of care and outcomes of cardiovascular patients.

The Congenital Heart Disease audit collects data on all cardiac surgery and therapeutic cardiac catheterisations procedures used to treat patients with congenital and acquired heart disease.

For acquired heart disease, the audit covers all arrhythmias \& cardiomyopathies in patients less than 16 years old only. For congenital heart disease, the audit collects data on both children and adult patients. The audit covers all specialist centers in the UK and Republic of Ireland.

The project aims to improve the quality of care for children and adults with congenital heart disease by providing national comparative analysis of procedure specific activity and outcomes of cardiac surgery and therapeutic cardiac catheterisation procedures. The audit also provides quality indicators for the antenatal detection of major congenital heart disease.

The current dataset is available from here:

http://www.ucl.ac.uk/nicor/audits/congenital/datasets

Conditions

  • Congenital Heart Disease (CHD)

Interventions

PROCEDURE

Cardiac Surgery

All patients with congential and acquired heart disease treated by cardiac surgery procedures.

PROCEDURE

Therapeutic cardiac catheterisations procedures

All patients with congential and acquired heart disease treated by therapeutic cardiac catheterisations procedures .

Sponsors & Collaborators

  • Society for Cardiothoracic Surgery in Great Britain & Ireland

    collaborator UNKNOWN

  • British Congenital Cardiac Association

    collaborator UNKNOWN

  • University College, London

    lead OTHER

Principal Investigators

  • Rodney Franklin, MD · Royal Brompton & Harefield NHS Foundation Trust

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-04-30
Primary Completion
2017-03-31
Completion
2017-03-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02303535 on ClinicalTrials.gov